Univariable and multivariable logistic regressions for complete response after Ven-Aza treatment
| Variable . | Univariable analysis . | Multivariable analysis . | ||||
|---|---|---|---|---|---|---|
| OR . | 95% CI . | P value . | OR . | 95% CI . | P value . | |
| Monoblasts/CD45+ | 0.87 | 0.80-0.96 | .004 | 0.24 | 0.07-0.56 | .005 |
| Age, y | 1.01 | 1.00-1.01 | .2 | 1.05 | 1.00-1.13 | .12 |
| Log10(WBC) | 0.83 | 0.69-0.99 | .041 | 0.07 | 0.01-0.43 | .011 |
| ELN 2024 | ||||||
| Favorable | — | — | — | — | ||
| Intermediate | 0.90 | 0.69-1.19 | .5 | 8.03 | 0.94-117 | .085 |
| Adverse | 0.77 | 0.60-0.99 | .048 | 0.17 | 0.03-0.76 | .028 |
| Variable . | Univariable analysis . | Multivariable analysis . | ||||
|---|---|---|---|---|---|---|
| OR . | 95% CI . | P value . | OR . | 95% CI . | P value . | |
| Monoblasts/CD45+ | 0.87 | 0.80-0.96 | .004 | 0.24 | 0.07-0.56 | .005 |
| Age, y | 1.01 | 1.00-1.01 | .2 | 1.05 | 1.00-1.13 | .12 |
| Log10(WBC) | 0.83 | 0.69-0.99 | .041 | 0.07 | 0.01-0.43 | .011 |
| ELN 2024 | ||||||
| Favorable | — | — | — | — | ||
| Intermediate | 0.90 | 0.69-1.19 | .5 | 8.03 | 0.94-117 | .085 |
| Adverse | 0.77 | 0.60-0.99 | .048 | 0.17 | 0.03-0.76 | .028 |
Bold face values point to significant (p<0.05) values in univariable and/or multivariables analyses.